Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity

Diabetes Care. 2007 Jan;30(1):147-9. doi: 10.2337/dc06-1628.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / genetics*
  • Female
  • Gene Expression Regulation*
  • Genetic Carrier Screening
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Infant, Newborn
  • Infant, Newborn, Diseases / genetics*
  • Insulin / blood
  • Insulin / therapeutic use
  • Male
  • Mutation*
  • Potassium Channels, Inwardly Rectifying / genetics*
  • Sulfonylurea Compounds / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Insulin
  • Kir6.2 channel
  • Potassium Channels, Inwardly Rectifying
  • Sulfonylurea Compounds